Tilray
TLRY
#5834
Rank
โ‚น100.08 B
Marketcap
โ‚น859.02
Share price
-2.63%
Change (1 day)
748.11%
Change (1 year)

Revenue for Tilray (TLRY)

Revenue in 2025 (TTM): โ‚น73.32 Billion

According to Tilray 's latest financial reports the company's current revenue (TTM ) is โ‚น76.07 Billion. an increase over the revenue in the year 2024 that were of โ‚น71.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tilray from 2012 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น75.16 B5.67%
2024 โ‚น71.13 B21.98%
2023 โ‚น58.31 B16.96%
2022 โ‚น49.86 B11.78%
2021 โ‚น44.60 B
2018 โ‚น2.34 B
2015 โ‚น0.13 B
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.53 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น58.33 B-23.32%๐Ÿ‡บ๐Ÿ‡ธ USA